They have also expanded this method for multiplexing capability using two different Raman dyes-labeled gold nanobeacons to successfully detect the presence of the erbB-2 and ki-67 breast cancer biomarkers [113]. This evidence concerns the gene ERBB2 and breast carcinoma.